How can I choose the best treatment of retinitis pigmentosa?
Since 2011, no treatment of retinitis pigmentosa has been available. Some studies suggest that the removal of 15,000 international units (IU) of vitamin and can slightly slow down the progression of the disease daily. These tests are not definitive and large doses of this vitamin can cause toxicity, so check your doctor before performing. Microchip implants, which are devices that are surgically built into the retina, develop to treat blindness that results from this disease. The person with retinitis pigmentosa should also wear sunglasses to protect the eyes from the effects of ultraviolet light.
Retinitis pigmentosa is a progressive eye disease involving the retina. Most often you can see damage to cells responsible for night vision. Symptoms include loss of night vision and reduced peripheral vision. As the disease deteriorates, central vision will be reduced. Symptoms are usually recorded for the first time in early childhood, but the development of serious loss of vision Yenhevkar was up to the earlyto the merge.
The cause of the state is known very little, except that it runs in families. Scientists identified 32 associated genes. Approximately one percent of the population is considered to be carriers of properties, but the actual diseases can only be seen in a fraction of this one percent.
A study was conducted to determine the efficiency of the microchip for the treatment of retinitis pigmentosa. The right eye of six patients with the disease was implanted by a microchip, while the left eye was left untreated. The evaluation followed by the implant surgery ranged from six to 18 months. No adverse effects have been reported and all patients have improved vision. Scientists have concluded that other clinical studies are needed to determine the safety and efficacy of this treatment.
Although this microchip retinitis pigmentosa is not treated cannot heal the damage caused by the condition, may increase the funkMine. Early research involving the effects of these implanted devices in blind patients suggests that they can restore certain visual skills. The ability to recognize everyday items and read a large print with the help of glasses is included. Other benefits include the ability to identify others and allow patients to work in a small field of view.
Other options that are examined for the treatment of retinitis pigmentosa include eye therapy and modified substances derived from certain types of algae. People in the early stages of this disease may benefit from ergotherapy. This treatment can maximize independence and help in lifestyle changes that the condition requires. It may also be useful to use a low hanging device that increases views of objects.